Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Syros Pharmaceuticals, Inc. (SYRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/18/2019 |
GN
| GBT Secures $150 Million Non-Dilutive Term Loan Financing |
| 12/18/2019 |
GN
| GBT and Syros Partner to Discover, Develop and Commercialize Novel Therapies for Sickle Cell Disease and Beta Thalassemia |
| 10/23/2018 |
GN
| Market Trends Toward New Normal in Syros Pharmaceuticals, Westlake Chemical Partners LP, SITO Mobile, ShotSpotter, Motorcar Parts of America, and Benefitfocus — Emerging Consolidated Expectations, Analyst Ratings |
| 05/21/2018 |
GN
| Report: Exploring Fundamental Drivers Behind Syros Pharmaceuticals, J & J Snack Foods, Wright Medical Group N.V, HCI Group, Tennant, and Ebix — New Horizons, Emerging Trends, and Upcoming Developments |
| 03/26/2018 |
GN
| Report: Developing Opportunities within AllianceBernstein Holding, Deutsche Bank Aktiengesellschaft, Syros Pharmaceuticals, Ply Gem, Ensco plc, and Berkshire Hills — Future Expectations, Projections Moving into 2018 |
| 01/24/2018 |
GN
| New Research Coverage Highlights Oracle, General Dynamics, Agile Therapeutics, Fidelity Southern, Syros Pharmaceuticals, and MSA Safety Incorporated — Consolidated Revenues, Company Growth, and Expectations for 2018 |
|
|